Clinical effects of an oral supplement rich in antioxidants on skin radiance in women by Dumoulin M, Gaudout D, Lemaire B

Get full text

Solid phase processing of polymers / by Ward, I. M. (Ian Macmillan), 1928-, Coates, P. D. (Phil D.), Dumoulin, M. M.

Impact of the native-state stability of human lysozyme variants on protein secretion by Pichia pastoris. by Kumita, JR, Johnson, R, Alcocer, M, Dumoulin, M, Holmqvist, F, McCammon, MG, Robinson, C, Archer, D, Dobson, C

The extracellular chaperone clusterin potently inhibits human lysozyme amyloid formation by interacting with prefibrillar species. by Kumita, JR, Poon, S, Caddy, G, Hagan, C, Dumoulin, M, Yerbury, J, Stewart, E, Robinson, C, Wilson, MR, Dobson, C

The role of active site flexible loops in catalysis and of zinc in conformational stability of Bacillus cereus 569/H/9 β-lactamase. by Montagner, C, Nigen, M, Jacquin, O, Willet, N, Dumoulin, M, Karsisiotis, A, Roberts, G, Damblon, C, Redfield, C, Matagne, A

A non-natural variant of human lysozyme (I59T) mimics the in vitro behaviour of the I56T variant that is responsible for a form of familial amyloidosis. by Hagan, C, Johnson, R, Dhulesia, A, Dumoulin, M, Dumont, J, De Genst, E, Christodoulou, J, Robinson, C, Dobson, C, Kumita, JR

Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations. by Dumoulin, M, Canet, D, Last, A, Pardon, E, Archer, D, Muyldermans, S, Wyns, L, Matagne, A, Robinson, C, Redfield, C, Dobson, C

Rationalising lysozyme amyloidosis: insights from the structure and solution dynamics of T70N lysozyme. by Johnson, R, Christodoulou, J, Dumoulin, M, Caddy, G, Alcocer, M, Murtagh, G, Kumita, JR, Larsson, G, Robinson, C, Archer, D, Luisi, B, Dobson, C

The significance of the location of mutations for the native-state dynamics of human lysozyme by Ahn, M, Hagan, C, Bernardo-Gancedo, A, De Genst, E, Newby, F, Christodoulou, J, Dhulesia, A, Dumoulin, M, Robinson, C, Dobson, C, Kumita, J

A nanobody binding to non-amyloidogenic regions of the protein human lysozyme enhances partial unfolding but inhibits amyloid fibril formation. by De Genst, E, Chan, P, Pardon, E, Hsu, S, Kumita, JR, Christodoulou, J, Menzer, L, Chirgadze, D, Robinson, C, Muyldermans, S, Matagne, A, Wyns, L, Dobson, C, Dumoulin, M

A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme. by Dumoulin, M, Last, A, Desmyter, A, Decanniere, K, Canet, D, Larsson, G, Spencer, A, Archer, D, Sasse, J, Muyldermans, S, Wyns, L, Redfield, C, Matagne, A, Robinson, C, Dobson, C

Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils. by Chan, P, Pardon, E, Menzer, L, De Genst, E, Kumita, JR, Christodoulou, J, Saerens, D, Brans, A, Bouillenne, F, Archer, D, Robinson, C, Muyldermans, S, Matagne, A, Redfield, C, Wyns, L, Dobson, C, Dumoulin, M